
Talimogene laherparepvec - Wikipedia
Talimogene laherparepvec is a genetically engineered herpes virus (an oncolytic herpes virus). Two genes were removed – one that shuts down an individual cell's defenses, and another that helps the virus evade the immune system – and a gene for human GM-CSF was added.
T-VEC (Imlygic™) - Melanoma Research Alliance
T-VEC is an oncolytic virus therapy, a treatment that uses a virus to infect and kill cancer cells while avoiding normal, healthy cells. T-VEC is made from a genetically modified herpes virus, commonly known as the cold sore virus.
IMLYGIC® (talimogene laherparepvec) | Patient Information
IMLYGIC ® (talimogene laherparepvec) is a prescription medication injected on the skin, beneath the skin, or in your lymph glands to treat a type of skin cancer called melanoma when it can no longer be surgically removed. IMLYGIC ® may not help …
FDA Approves T-VEC to Treat Metastatic Melanoma - NCI
2015年11月25日 · The FDA has approved the first oncolytic virus therapy, talimogene laherparepvec (T-VEC). The drug was approved for the treatment of metastatic melanoma that cannot be removed surgically.
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer …
Talimogene laherperepvec (T-VEC) is an injectable modified oncolytic herpes virus being developed for intratumoral injection, that produces granulocyte-macrophage colony-stimulating factor (GM-CSF) and enhances local and systemic antitumor immune responses.
IMLYGIC | FDA - U.S. Food and Drug Administration
2023年2月15日 · IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after...
Talimogene laherparepvec (T-VEC) for the treatment of advanced …
Talimogene laherperepvec (T-VEC) is an injectable modified oncolytic herpes virus being developed for the treatment of advanced melanoma. Pre-clinical studies have shown that T-VEC preferentially infects melanoma cells and exerts antitumor activity through directly mediating cell death and by augmenting local and even distant immune responses.
Talimogene laherparepvec (T-VEC) - Cancer Research UK
Talimogene laherparepvec (T-VEC) is an immunotherapy treatment for melanoma skin cancer. Find out how it works, when you have it, side effects and other important information.
Talimogene Laherparepvec (T-VEC): A Review of the Recent …
In this article, we will provide a review on OVs and the application of T-VEC in melanoma monotherapy and combination therapy. In addition, we will review the recent progress of T-VEC application in other cutaneous cancer types.
T-VEC: Revolutionary treatment for melanoma skin cancer
2021年2月15日 · A new treatment called T-VEC has revolutionized the course of advanced melanoma treatment for thousands of patients. Melanoma is caused when the cells that provide the tan or brown pigment in skin grow too quickly.